Canadian Manufacturing

Aurora Cannabis reports Q4 revenue expected to be between $50M and $55M

The Canadian Press

Canadian Manufacturing
Financing Operations Regulation Sales & Marketing Small Business Food & Beverage

The spike is supported by Canada's adult consumer use market as of October 2018 and shipments of medical cannabis to Aurora's roughly 71,000 patients in Canada

PHOTO: Bob Dass via Flickr

EDMONTON – Aurora Cannabis Inc. says it expects to report second-quarter revenue of between $50 million and $55 million.

Analysts had expected revenue at the marijuana producer to total about $67 million for the quarter ended Dec. 31, according to Thomson Reuters Eikon.

Aurora says the result for the quarter is up from $11.7 million in the same quarter a year ago and better than the $29.7 million for the quarter ended Sept. 30.

The increase was driven by the start of the adult consumer use market in Canada in October and shipments of medical cannabis to Aurora’s base of roughly 71,000 patients in Canada.


The company says its production capacity is now about 100,000 kilograms per year, up from 70,000 kg in November.

Annual production capacity is expected to grow to 150,000 kg by the end of the current quarter, with Aurora scheduled to release is full quarterly results on Feb. 11.


Stories continue below